SAN

81

+0.43%↑

MRK1

120.65

+1.99%↑

SHL.DE

44.4

-0.45%↓

ARGX

724.6

+0.06%↑

FRE

47.26

-2.38%↓

SAN

81

+0.43%↑

MRK1

120.65

+1.99%↑

SHL.DE

44.4

-0.45%↓

ARGX

724.6

+0.06%↑

FRE

47.26

-2.38%↓

SAN

81

+0.43%↑

MRK1

120.65

+1.99%↑

SHL.DE

44.4

-0.45%↓

ARGX

724.6

+0.06%↑

FRE

47.26

-2.38%↓

SAN

81

+0.43%↑

MRK1

120.65

+1.99%↑

SHL.DE

44.4

-0.45%↓

ARGX

724.6

+0.06%↑

FRE

47.26

-2.38%↓

SAN

81

+0.43%↑

MRK1

120.65

+1.99%↑

SHL.DE

44.4

-0.45%↓

ARGX

724.6

+0.06%↑

FRE

47.26

-2.38%↓

Search

EssilorLuxottica SA

Slēgts

SektorsVeselības aprūpe

278.1 -1.73

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

276

Max

283.2

Galvenie mērījumi

By Trading Economics

Ienākumi

394M

1.4B

Pārdošana

806M

14B

P/E

Sektora vidējais

61.996

77.671

Dividenžu ienesīgums

1.23

Peļņas marža

9.89

Darbinieki

200,076

EBITDA

-24M

3.6B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+16.72% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

1.23%

2.35%

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

14B

148B

Iepriekšējā atvēršanas cena

279.83

Iepriekšējā slēgšanas cena

278.1

Ziņu noskaņojums

By Acuity

18%

82%

25 / 374 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bearish Evidence

EssilorLuxottica SA Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 12. dec. 07:31 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica Snaps Up Belgium's Signifeye

2025. g. 9. dec. 15:09 UTC

Galvenie tirgus virzītāji

Ray-Ban Owner EssilorLuxottica Shares Fall on Google's Planned AI Glasses Launch

2025. g. 17. okt. 09:35 UTC

Galvenie tirgus virzītāji

EssilorLuxottica Shares Soar After Revenue Accelerates Ahead of Forecasts

2025. g. 16. okt. 17:12 UTC

Peļņas

Ray-Ban Maker EssilorLuxottica's Revenue Surges to Quarterly Record -- Update

2025. g. 16. okt. 16:53 UTC

Peļņas

Ray-Ban Maker EssilorLuxottica's Revenue Surges to Quarterly Record

2025. g. 6. okt. 05:54 UTC

Galvenie tirgus virzītāji

Nikon Shares Rise After EssilorLuxottica Raises Stake

2025. g. 12. dec. 07:03 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica: Signifeye Offers Care in 15 Centers, Clinics Across Flanders Region

2025. g. 12. dec. 07:02 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica To Buy Belgian Ophthalmology Platform Signifeye

2025. g. 9. dec. 11:07 UTC

Tirgus saruna

EssilorLuxottica Faces a Particularly Bright Outlook in 2026 -- Market Talk

2025. g. 27. nov. 10:23 UTC

Tirgus saruna
Peļņas

EssilorLuxottica Looks Set to Benefit From Smart Eyewear Boom -- Market Talk

2025. g. 16. okt. 16:05 UTC

Peļņas

EssilorLuxottica CEO: "As We Enter the Fourth Quarter, We Carry Strong Momentum"

2025. g. 16. okt. 16:03 UTC

Peļņas

EssilorLuxottica Sees Adj Oper Margin Between 19% and 20% by End of 2026

2025. g. 16. okt. 16:03 UTC

Peļņas

EssilorLuxottica Sees 2022-2026 Mid-Single-Digit Annual Revenue Growth CER

2025. g. 16. okt. 16:03 UTC

Peļņas

EssilorLuxottica Backs Long-Term Guidance

2025. g. 16. okt. 16:02 UTC

Peļņas

EssilorLuxottica 3Q Direct to Consumer Rev EUR3.64B

2025. g. 16. okt. 16:02 UTC

Peļņas

EssilorLuxottica 3Q Professional Solutions Rev EUR3.22B

2025. g. 16. okt. 16:02 UTC

Peļņas

Analysts Had Seen EssilorLuxottica 3Q Rev at EUR6.75B

2025. g. 16. okt. 16:02 UTC

Peļņas

EssilorLuxottica 3Q Rev EUR6.87B

2025. g. 16. okt. 16:02 UTC

Peļņas

EssilorLuxottica: This Was Best Quarterly Performance Ever for the Group

2025. g. 16. okt. 16:01 UTC

Peļņas

EssilorLuxottica 3Q Rev Rose 12% on Year at Constant Currency

2025. g. 15. okt. 16:51 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica Doesn't Disclose Financial Details

2025. g. 15. okt. 16:50 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica: RetinAI Partners With Pharmaceutical Companies, Research Organizations

2025. g. 15. okt. 16:49 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica: Deal Reinforces the Group's Med-Tech Journey

2025. g. 15. okt. 16:48 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica: Ikerian Specializes in Artificial Intelligence, Data Management in Eyecare

2025. g. 15. okt. 16:48 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica: Ikerian Is a Health Technology Company, Operating Under the RetinAI Brand

2025. g. 15. okt. 16:47 UTC

Iegādes, apvienošanās, pārņemšana

EssilorLuxottica Buys Ikerian

2025. g. 10. okt. 10:00 UTC

Tirgus saruna

EssilorLuxottica Smart-Glasses Push Challenged as Competition Heats Up -- Market Talk

2025. g. 3. okt. 10:14 UTC

Tirgus saruna

EssilorLuxottica Should Keep Up the Momentum Driven by Smart Glasses -- Market Talk

2025. g. 18. sept. 11:10 UTC

Tirgus saruna

Meta Smartglasses Sales to Boost EssilorLuxottica Revenue -- Market Talk

2025. g. 16. sept. 18:44 UTC

Tirgus saruna

EssilorLuxottica Well-Positioned in Growing Smart-Glasses Market -- Market Talk

Salīdzinājums

Cenas izmaiņa

EssilorLuxottica SA Prognoze

Cenas mērķis

By TipRanks

16.72% augšup

Prognoze 12 mēnešiem

Vidējais 329.73 EUR  16.72%

Augstākais 365 EUR

Zemākais 248 EUR

Pamatojoties uz 12 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi EssilorLuxottica SA — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

12 ratings

10

Pirkt

2

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

243.3 / 250.9Atbalsts un pretestība

Īstermiņā

Strong Bearish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

No Evidence

Noskaņojums

By Acuity

25 / 374 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par EssilorLuxottica SA

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.
help-icon Live chat